1 Scope of the Report 1.1 Market Introduction 1.2 Years Considered 1.3 Research Objectives 1.4 Market Research Methodology 1.5 Research Process and Data Source 1.6 Economic Indicators 1.7 Currency Considered 2 Executive Summary 2.1 World Market Overview 2.1.1 Global Pneumonia Vaccine Annual Sales 2017-2028 2.1.2 World Current & Future Analysis for Pneumonia Vaccine by Geographic Region, 2017, 2022 & 2028 2.1.3 World Current & Future Analysis for Pneumonia Vaccine by Country/Region, 2017, 2022 & 2028 2.2 Pneumonia Vaccine Segment by Type 2.2.1 Pneumococcal Conjugate Vaccine (PCV13) 2.2.2 Pneumococcal Polysaccharide Vaccine (PPSV23) 2.2.3 Other 2.3 Pneumonia Vaccine Sales by Type 2.3.1 Global Pneumonia Vaccine Sales Market Share by Type (2017-2022) 2.3.2 Global Pneumonia Vaccine Revenue and Market Share by Type (2017-2022) 2.3.3 Global Pneumonia Vaccine Sale Price by Type (2017-2022) 2.4 Pneumonia Vaccine Segment by Application 2.4.1 Pneumonia 2.4.2 Meningitis 2.4.3 Sepsis 2.5 Pneumonia Vaccine Sales by Application 2.5.1 Global Pneumonia Vaccine Sale Market Share by Application (2017-2022) 2.5.2 Global Pneumonia Vaccine Revenue and Market Share by Application (2017-2022) 2.5.3 Global Pneumonia Vaccine Sale Price by Application (2017-2022) 3 Global Pneumonia Vaccine by Company 3.1 Global Pneumonia Vaccine Breakdown Data by Company 3.1.1 Global Pneumonia Vaccine Annual Sales by Company (2020-2022) 3.1.2 Global Pneumonia Vaccine Sales Market Share by Company (2020-2022) 3.2 Global Pneumonia Vaccine Annual Revenue by Company (2020-2022) 3.2.1 Global Pneumonia Vaccine Revenue by Company (2020-2022) 3.2.2 Global Pneumonia Vaccine Revenue Market Share by Company (2020-2022) 3.3 Global Pneumonia Vaccine Sale Price by Company 3.4 Key Manufacturers Pneumonia Vaccine Producing Area Distribution, Sales Area, Product Type 3.4.1 Key Manufacturers Pneumonia Vaccine Product Location Distribution 3.4.2 Players Pneumonia Vaccine Products Offered 3.5 Market Concentration Rate Analysis 3.5.1 Competition Landscape Analysis 3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022) 3.6 New Products and Potential Entrants 3.7 Mergers & Acquisitions, Expansion 4 World Historic Review for Pneumonia Vaccine by Geographic Region 4.1 World Historic Pneumonia Vaccine Market Size by Geographic Region (2017-2022) 4.1.1 Global Pneumonia Vaccine Annual Sales by Geographic Region (2017-2022) 4.1.2 Global Pneumonia Vaccine Annual Revenue by Geographic Region 4.2 World Historic Pneumonia Vaccine Market Size by Country/Region (2017-2022) 4.2.1 Global Pneumonia Vaccine Annual Sales by Country/Region (2017-2022) 4.2.2 Global Pneumonia Vaccine Annual Revenue by Country/Region 4.3 Americas Pneumonia Vaccine Sales Growth 4.4 APAC Pneumonia Vaccine Sales Growth 4.5 Europe Pneumonia Vaccine Sales Growth 4.6 Middle East & Africa Pneumonia Vaccine Sales Growth 5 Americas 5.1 Americas Pneumonia Vaccine Sales by Country 5.1.1 Americas Pneumonia Vaccine Sales by Country (2017-2022) 5.1.2 Americas Pneumonia Vaccine Revenue by Country (2017-2022) 5.2 Americas Pneumonia Vaccine Sales by Type 5.3 Americas Pneumonia Vaccine Sales by Application 5.4 United States 5.5 Canada 5.6 Mexico 5.7 Brazil 6 APAC 6.1 APAC Pneumonia Vaccine Sales by Region 6.1.1 APAC Pneumonia Vaccine Sales by Region (2017-2022) 6.1.2 APAC Pneumonia Vaccine Revenue by Region (2017-2022) 6.2 APAC Pneumonia Vaccine Sales by Type 6.3 APAC Pneumonia Vaccine Sales by Application 6.4 China 6.5 Japan 6.6 South Korea 6.7 Southeast Asia 6.8 India 6.9 Australia 6.10 China Taiwan 7 Europe 7.1 Europe Pneumonia Vaccine by Country 7.1.1 Europe Pneumonia Vaccine Sales by Country (2017-2022) 7.1.2 Europe Pneumonia Vaccine Revenue by Country (2017-2022) 7.2 Europe Pneumonia Vaccine Sales by Type 7.3 Europe Pneumonia Vaccine Sales by Application 7.4 Germany 7.5 France 7.6 UK 7.7 Italy 7.8 Russia 8 Middle East & Africa 8.1 Middle East & Africa Pneumonia Vaccine by Country 8.1.1 Middle East & Africa Pneumonia Vaccine Sales by Country (2017-2022) 8.1.2 Middle East & Africa Pneumonia Vaccine Revenue by Country (2017-2022) 8.2 Middle East & Africa Pneumonia Vaccine Sales by Type 8.3 Middle East & Africa Pneumonia Vaccine Sales by Application 8.4 Egypt 8.5 South Africa 8.6 Israel 8.7 Turkey 8.8 GCC Countries 9 Market Drivers, Challenges and Trends 9.1 Market Drivers & Growth Opportunities 9.2 Market Challenges & Risks 9.3 Industry Trends 10 Manufacturing Cost Structure Analysis 10.1 Raw Material and Suppliers 10.2 Manufacturing Cost Structure Analysis of Pneumonia Vaccine 10.3 Manufacturing Process Analysis of Pneumonia Vaccine 10.4 Industry Chain Structure of Pneumonia Vaccine 11 Marketing, Distributors and Customer 11.1 Sales Channel 11.1.1 Direct Channels 11.1.2 Indirect Channels 11.2 Pneumonia Vaccine Distributors 11.3 Pneumonia Vaccine Customer 12 World Forecast Review for Pneumonia Vaccine by Geographic Region 12.1 Global Pneumonia Vaccine Market Size Forecast by Region 12.1.1 Global Pneumonia Vaccine Forecast by Region (2023-2028) 12.1.2 Global Pneumonia Vaccine Annual Revenue Forecast by Region (2023-2028) 12.2 Americas Forecast by Country 12.3 APAC Forecast by Region 12.4 Europe Forecast by Country 12.5 Middle East & Africa Forecast by Country 12.6 Global Pneumonia Vaccine Forecast by Type 12.7 Global Pneumonia Vaccine Forecast by Application 13 Key Players Analysis 13.1 Pfizer Inc. 13.1.1 Pfizer Inc. Company Information 13.1.2 Pfizer Inc. Pneumonia Vaccine Product Offered 13.1.3 Pfizer Inc. Pneumonia Vaccine Sales, Revenue, Price and Gross Margin (2020-2022) 13.1.4 Pfizer Inc. Main Business Overview 13.1.5 Pfizer Inc. Latest Developments 13.2 Glaxosmithkline Plc. 13.2.1 Glaxosmithkline Plc. Company Information 13.2.2 Glaxosmithkline Plc. Pneumonia Vaccine Product Offered 13.2.3 Glaxosmithkline Plc. Pneumonia Vaccine Sales, Revenue, Price and Gross Margin (2020-2022) 13.2.4 Glaxosmithkline Plc. Main Business Overview 13.2.5 Glaxosmithkline Plc. Latest Developments 13.3 Merck & Co., Inc. 13.3.1 Merck & Co., Inc. Company Information 13.3.2 Merck & Co., Inc. Pneumonia Vaccine Product Offered 13.3.3 Merck & Co., Inc. Pneumonia Vaccine Sales, Revenue, Price and Gross Margin (2020-2022) 13.3.4 Merck & Co., Inc. Main Business Overview 13.3.5 Merck & Co., Inc. Latest Developments 13.4 Sanofi Pasteur 13.4.1 Sanofi Pasteur Company Information 13.4.2 Sanofi Pasteur Pneumonia Vaccine Product Offered 13.4.3 Sanofi Pasteur Pneumonia Vaccine Sales, Revenue, Price and Gross Margin (2020-2022) 13.4.4 Sanofi Pasteur Main Business Overview 13.4.5 Sanofi Pasteur Latest Developments 13.5 Serum Institute of India Pvt. Ltd. 13.5.1 Serum Institute of India Pvt. Ltd. Company Information 13.5.2 Serum Institute of India Pvt. Ltd. Pneumonia Vaccine Product Offered 13.5.3 Serum Institute of India Pvt. Ltd. Pneumonia Vaccine Sales, Revenue, Price and Gross Margin (2020-2022) 13.5.4 Serum Institute of India Pvt. Ltd. Main Business Overview 13.5.5 Serum Institute of India Pvt. Ltd. Latest Developments 13.6 Johnson & Johnson 13.6.1 Johnson & Johnson Company Information 13.6.2 Johnson & Johnson Pneumonia Vaccine Product Offered 13.6.3 Johnson & Johnson Pneumonia Vaccine Sales, Revenue, Price and Gross Margin (2020-2022) 13.6.4 Johnson & Johnson Main Business Overview 13.6.5 Johnson & Johnson Latest Developments 13.7 Astellas Pharma Inc. 13.7.1 Astellas Pharma Inc. Company Information 13.7.2 Astellas Pharma Inc. Pneumonia Vaccine Product Offered 13.7.3 Astellas Pharma Inc. Pneumonia Vaccine Sales, Revenue, Price and Gross Margin (2020-2022) 13.7.4 Astellas Pharma Inc. Main Business Overview 13.7.5 Astellas Pharma Inc. Latest Developments 13.8 Astrazeneca Plc. 13.8.1 Astrazeneca Plc. Company Information 13.8.2 Astrazeneca Plc. Pneumonia Vaccine Product Offered 13.8.3 Astrazeneca Plc. Pneumonia Vaccine Sales, Revenue, Price and Gross Margin (2020-2022) 13.8.4 Astrazeneca Plc. Main Business Overview 13.8.5 Astrazeneca Plc. Latest Developments 13.9 CSL Limited 13.9.1 CSL Limited Company Information 13.9.2 CSL Limited Pneumonia Vaccine Product Offered 13.9.3 CSL Limited Pneumonia Vaccine Sales, Revenue, Price and Gross Margin (2020-2022) 13.9.4 CSL Limited Main Business Overview 13.9.5 CSL Limited Latest Developments 13.10 Emergent Biosolutions 13.10.1 Emergent Biosolutions Company Information 13.10.2 Emergent Biosolutions Pneumonia Vaccine Product Offered 13.10.3 Emergent Biosolutions Pneumonia Vaccine Sales, Revenue, Price and Gross Margin (2020-2022) 13.10.4 Emergent Biosolutions Main Business Overview 13.10.5 Emergent Biosolutions Latest Developments 13.11 Walvax Biotechnology 13.11.1 Walvax Biotechnology Company Information 13.11.2 Walvax Biotechnology Pneumonia Vaccine Product Offered 13.11.3 Walvax Biotechnology Pneumonia Vaccine Sales, Revenue, Price and Gross Margin (2020-2022) 13.11.4 Walvax Biotechnology Main Business Overview 13.11.5 Walvax Biotechnology Latest Developments 13.12 Royal (Wuxi) Bio-Pharmaceutical 13.12.1 Royal (Wuxi) Bio-Pharmaceutical Company Information 13.12.2 Royal (Wuxi) Bio-Pharmaceutical Pneumonia Vaccine Product Offered 13.12.3 Royal (Wuxi) Bio-Pharmaceutical Pneumonia Vaccine Sales, Revenue, Price and Gross Margin (2020-2022) 13.12.4 Royal (Wuxi) Bio-Pharmaceutical Main Business Overview 13.12.5 Royal (Wuxi) Bio-Pharmaceutical Latest Developments 13.13 Zhifei Biologic 13.13.1 Zhifei Biologic Company Information 13.13.2 Zhifei Biologic Pneumonia Vaccine Product Offered 13.13.3 Zhifei Biologic Pneumonia Vaccine Sales, Revenue, Price and Gross Margin (2020-2022) 13.13.4 Zhifei Biologic Main Business Overview 13.13.5 Zhifei Biologic Latest Developments 14 Research Findings and Conclusion

List of Tables Table 1. Pneumonia Vaccine Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions) Table 2. Pneumonia Vaccine Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions) Table 3. Major Players of Pneumococcal Conjugate Vaccine (PCV13) Table 4. Major Players of Pneumococcal Polysaccharide Vaccine (PPSV23) Table 5. Major Players of Other Table 6. Global Pneumonia Vaccine Sales by Type (2017-2022) & (K Doses) Table 7. Global Pneumonia Vaccine Sales Market Share by Type (2017-2022) Table 8. Global Pneumonia Vaccine Revenue by Type (2017-2022) & ($ million) Table 9. Global Pneumonia Vaccine Revenue Market Share by Type (2017-2022) Table 10. Global Pneumonia Vaccine Sale Price by Type (2017-2022) & (USD/Dose) Table 11. Global Pneumonia Vaccine Sales by Application (2017-2022) & (K Doses) Table 12. Global Pneumonia Vaccine Sales Market Share by Application (2017-2022) Table 13. Global Pneumonia Vaccine Revenue by Application (2017-2022) Table 14. Global Pneumonia Vaccine Revenue Market Share by Application (2017-2022) Table 15. Global Pneumonia Vaccine Sale Price by Application (2017-2022) & (USD/Dose) Table 16. Global Pneumonia Vaccine Sales by Company (2020-2022) & (K Doses) Table 17. Global Pneumonia Vaccine Sales Market Share by Company (2020-2022) Table 18. Global Pneumonia Vaccine Revenue by Company (2020-2022) ($ Millions) Table 19. Global Pneumonia Vaccine Revenue Market Share by Company (2020-2022) Table 20. Global Pneumonia Vaccine Sale Price by Company (2020-2022) & (USD/Dose) Table 21. Key Manufacturers Pneumonia Vaccine Producing Area Distribution and Sales Area Table 22. Players Pneumonia Vaccine Products Offered Table 23. Pneumonia Vaccine Concentration Ratio (CR3, CR5 and CR10) & (2020-2022) Table 24. New Products and Potential Entrants Table 25. Mergers & Acquisitions, Expansion Table 26. Global Pneumonia Vaccine Sales by Geographic Region (2017-2022) & (K Doses) Table 27. Global Pneumonia Vaccine Sales Market Share Geographic Region (2017-2022) Table 28. Global Pneumonia Vaccine Revenue by Geographic Region (2017-2022) & ($ millions) Table 29. Global Pneumonia Vaccine Revenue Market Share by Geographic Region (2017-2022) Table 30. Global Pneumonia Vaccine Sales by Country/Region (2017-2022) & (K Doses) Table 31. Global Pneumonia Vaccine Sales Market Share by Country/Region (2017-2022) Table 32. Global Pneumonia Vaccine Revenue by Country/Region (2017-2022) & ($ millions) Table 33. Global Pneumonia Vaccine Revenue Market Share by Country/Region (2017-2022) Table 34. Americas Pneumonia Vaccine Sales by Country (2017-2022) & (K Doses) Table 35. Americas Pneumonia Vaccine Sales Market Share by Country (2017-2022) Table 36. Americas Pneumonia Vaccine Revenue by Country (2017-2022) & ($ Millions) Table 37. Americas Pneumonia Vaccine Revenue Market Share by Country (2017-2022) Table 38. Americas Pneumonia Vaccine Sales by Type (2017-2022) & (K Doses) Table 39. Americas Pneumonia Vaccine Sales Market Share by Type (2017-2022) Table 40. Americas Pneumonia Vaccine Sales by Application (2017-2022) & (K Doses) Table 41. Americas Pneumonia Vaccine Sales Market Share by Application (2017-2022) Table 42. APAC Pneumonia Vaccine Sales by Region (2017-2022) & (K Doses) Table 43. APAC Pneumonia Vaccine Sales Market Share by Region (2017-2022) Table 44. APAC Pneumonia Vaccine Revenue by Region (2017-2022) & ($ Millions) Table 45. APAC Pneumonia Vaccine Revenue Market Share by Region (2017-2022) Table 46. APAC Pneumonia Vaccine Sales by Type (2017-2022) & (K Doses) Table 47. APAC Pneumonia Vaccine Sales Market Share by Type (2017-2022) Table 48. APAC Pneumonia Vaccine Sales by Application (2017-2022) & (K Doses) Table 49. APAC Pneumonia Vaccine Sales Market Share by Application (2017-2022) Table 50. Europe Pneumonia Vaccine Sales by Country (2017-2022) & (K Doses) Table 51. Europe Pneumonia Vaccine Sales Market Share by Country (2017-2022) Table 52. Europe Pneumonia Vaccine Revenue by Country (2017-2022) & ($ Millions) Table 53. Europe Pneumonia Vaccine Revenue Market Share by Country (2017-2022) Table 54. Europe Pneumonia Vaccine Sales by Type (2017-2022) & (K Doses) Table 55. Europe Pneumonia Vaccine Sales Market Share by Type (2017-2022) Table 56. Europe Pneumonia Vaccine Sales by Application (2017-2022) & (K Doses) Table 57. Europe Pneumonia Vaccine Sales Market Share by Application (2017-2022) Table 58. Middle East & Africa Pneumonia Vaccine Sales by Country (2017-2022) & (K Doses) Table 59. Middle East & Africa Pneumonia Vaccine Sales Market Share by Country (2017-2022) Table 60. Middle East & Africa Pneumonia Vaccine Revenue by Country (2017-2022) & ($ Millions) Table 61. Middle East & Africa Pneumonia Vaccine Revenue Market Share by Country (2017-2022) Table 62. Middle East & Africa Pneumonia Vaccine Sales by Type (2017-2022) & (K Doses) Table 63. Middle East & Africa Pneumonia Vaccine Sales Market Share by Type (2017-2022) Table 64. Middle East & Africa Pneumonia Vaccine Sales by Application (2017-2022) & (K Doses) Table 65. Middle East & Africa Pneumonia Vaccine Sales Market Share by Application (2017-2022) Table 66. Key Market Drivers & Growth Opportunities of Pneumonia Vaccine Table 67. Key Market Challenges & Risks of Pneumonia Vaccine Table 68. Key Industry Trends of Pneumonia Vaccine Table 69. Pneumonia Vaccine Raw Material Table 70. Key Suppliers of Raw Materials Table 71. Pneumonia Vaccine Distributors List Table 72. Pneumonia Vaccine Customer List Table 73. Global Pneumonia Vaccine Sales Forecast by Region (2023-2028) & (K Doses) Table 74. Global Pneumonia Vaccine Sales Market Forecast by Region Table 75. Global Pneumonia Vaccine Revenue Forecast by Region (2023-2028) & ($ millions) Table 76. Global Pneumonia Vaccine Revenue Market Share Forecast by Region (2023-2028) Table 77. Americas Pneumonia Vaccine Sales Forecast by Country (2023-2028) & (K Doses) Table 78. Americas Pneumonia Vaccine Revenue Forecast by Country (2023-2028) & ($ millions) Table 79. APAC Pneumonia Vaccine Sales Forecast by Region (2023-2028) & (K Doses) Table 80. APAC Pneumonia Vaccine Revenue Forecast by Region (2023-2028) & ($ millions) Table 81. Europe Pneumonia Vaccine Sales Forecast by Country (2023-2028) & (K Doses) Table 82. Europe Pneumonia Vaccine Revenue Forecast by Country (2023-2028) & ($ millions) Table 83. Middle East & Africa Pneumonia Vaccine Sales Forecast by Country (2023-2028) & (K Doses) Table 84. Middle East & Africa Pneumonia Vaccine Revenue Forecast by Country (2023-2028) & ($ millions) Table 85. Global Pneumonia Vaccine Sales Forecast by Type (2023-2028) & (K Doses) Table 86. Global Pneumonia Vaccine Sales Market Share Forecast by Type (2023-2028) Table 87. Global Pneumonia Vaccine Revenue Forecast by Type (2023-2028) & ($ Millions) Table 88. Global Pneumonia Vaccine Revenue Market Share Forecast by Type (2023-2028) Table 89. Global Pneumonia Vaccine Sales Forecast by Application (2023-2028) & (K Doses) Table 90. Global Pneumonia Vaccine Sales Market Share Forecast by Application (2023-2028) Table 91. Global Pneumonia Vaccine Revenue Forecast by Application (2023-2028) & ($ Millions) Table 92. Global Pneumonia Vaccine Revenue Market Share Forecast by Application (2023-2028) Table 93. Pfizer Inc. Basic Information, Pneumonia Vaccine Manufacturing Base, Sales Area and Its Competitors Table 94. Pfizer Inc. Pneumonia Vaccine Product Offered Table 95. Pfizer Inc. Pneumonia Vaccine Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2022) Table 96. Pfizer Inc. Main Business Table 97. Pfizer Inc. Latest Developments Table 98. Glaxosmithkline Plc. Basic Information, Pneumonia Vaccine Manufacturing Base, Sales Area and Its Competitors Table 99. Glaxosmithkline Plc. Pneumonia Vaccine Product Offered Table 100. Glaxosmithkline Plc. Pneumonia Vaccine Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2022) Table 101. Glaxosmithkline Plc. Main Business Table 102. Glaxosmithkline Plc. Latest Developments Table 103. Merck & Co., Inc. Basic Information, Pneumonia Vaccine Manufacturing Base, Sales Area and Its Competitors Table 104. Merck & Co., Inc. Pneumonia Vaccine Product Offered Table 105. Merck & Co., Inc. Pneumonia Vaccine Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2022) Table 106. Merck & Co., Inc. Main Business Table 107. Merck & Co., Inc. Latest Developments Table 108. Sanofi Pasteur Basic Information, Pneumonia Vaccine Manufacturing Base, Sales Area and Its Competitors Table 109. Sanofi Pasteur Pneumonia Vaccine Product Offered Table 110. Sanofi Pasteur Pneumonia Vaccine Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2022) Table 111. Sanofi Pasteur Main Business Table 112. Sanofi Pasteur Latest Developments Table 113. Serum Institute of India Pvt. Ltd. Basic Information, Pneumonia Vaccine Manufacturing Base, Sales Area and Its Competitors Table 114. Serum Institute of India Pvt. Ltd. Pneumonia Vaccine Product Offered Table 115. Serum Institute of India Pvt. Ltd. Pneumonia Vaccine Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2022) Table 116. Serum Institute of India Pvt. Ltd. Main Business Table 117. Serum Institute of India Pvt. Ltd. Latest Developments Table 118. Johnson & Johnson Basic Information, Pneumonia Vaccine Manufacturing Base, Sales Area and Its Competitors Table 119. Johnson & Johnson Pneumonia Vaccine Product Offered Table 120. Johnson & Johnson Pneumonia Vaccine Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2022) Table 121. Johnson & Johnson Main Business Table 122. Johnson & Johnson Latest Developments Table 123. Astellas Pharma Inc. Basic Information, Pneumonia Vaccine Manufacturing Base, Sales Area and Its Competitors Table 124. Astellas Pharma Inc. Pneumonia Vaccine Product Offered Table 125. Astellas Pharma Inc. Pneumonia Vaccine Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2022) Table 126. Astellas Pharma Inc. Main Business Table 127. Astellas Pharma Inc. Latest Developments Table 128. Astrazeneca Plc. Basic Information, Pneumonia Vaccine Manufacturing Base, Sales Area and Its Competitors Table 129. Astrazeneca Plc. Pneumonia Vaccine Product Offered Table 130. Astrazeneca Plc. Pneumonia Vaccine Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2022) Table 131. Astrazeneca Plc. Main Business Table 132. Astrazeneca Plc. Latest Developments Table 133. CSL Limited Basic Information, Pneumonia Vaccine Manufacturing Base, Sales Area and Its Competitors Table 134. CSL Limited Pneumonia Vaccine Product Offered Table 135. CSL Limited Pneumonia Vaccine Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2022) Table 136. CSL Limited Main Business Table 137. CSL Limited Latest Developments Table 138. Emergent Biosolutions Basic Information, Pneumonia Vaccine Manufacturing Base, Sales Area and Its Competitors Table 139. Emergent Biosolutions Pneumonia Vaccine Product Offered Table 140. Emergent Biosolutions Pneumonia Vaccine Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2022) Table 141. Emergent Biosolutions Main Business Table 142. Emergent Biosolutions Latest Developments Table 143. Walvax Biotechnology Basic Information, Pneumonia Vaccine Manufacturing Base, Sales Area and Its Competitors Table 144. Walvax Biotechnology Pneumonia Vaccine Product Offered Table 145. Walvax Biotechnology Pneumonia Vaccine Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2022) Table 146. Walvax Biotechnology Main Business Table 147. Walvax Biotechnology Latest Developments Table 148. Royal (Wuxi) Bio-Pharmaceutical Basic Information, Pneumonia Vaccine Manufacturing Base, Sales Area and Its Competitors Table 149. Royal (Wuxi) Bio-Pharmaceutical Pneumonia Vaccine Product Offered Table 150. Royal (Wuxi) Bio-Pharmaceutical Pneumonia Vaccine Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2022) Table 151. Royal (Wuxi) Bio-Pharmaceutical Main Business Table 152. Royal (Wuxi) Bio-Pharmaceutical Latest Developments Table 153. Zhifei Biologic Basic Information, Pneumonia Vaccine Manufacturing Base, Sales Area and Its Competitors Table 154. Zhifei Biologic Pneumonia Vaccine Product Offered Table 155. Zhifei Biologic Pneumonia Vaccine Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2022) Table 156. Zhifei Biologic Main Business Table 157. Zhifei Biologic Latest Developments List of Figures Figure 1. Picture of Pneumonia Vaccine Figure 2. Pneumonia Vaccine Report Years Considered Figure 3. Research Objectives Figure 4. Research Methodology Figure 5. Research Process and Data Source Figure 6. Global Pneumonia Vaccine Sales Growth Rate 2017-2028 (K Doses) Figure 7. Global Pneumonia Vaccine Revenue Growth Rate 2017-2028 ($ Millions) Figure 8. Pneumonia Vaccine Sales by Region (2021 & 2028) & ($ millions) Figure 9. Product Picture of Pneumococcal Conjugate Vaccine (PCV13) Figure 10. Product Picture of Pneumococcal Polysaccharide Vaccine (PPSV23) Figure 11. Product Picture of Other Figure 12. Global Pneumonia Vaccine Sales Market Share by Type in 2021 Figure 13. Global Pneumonia Vaccine Revenue Market Share by Type (2017-2022) Figure 14. Pneumonia Vaccine Consumed in Pneumonia Figure 15. Global Pneumonia Vaccine Market: Pneumonia (2017-2022) & (K Doses) Figure 16. Pneumonia Vaccine Consumed in Meningitis Figure 17. Global Pneumonia Vaccine Market: Meningitis (2017-2022) & (K Doses) Figure 18. Pneumonia Vaccine Consumed in Sepsis Figure 19. Global Pneumonia Vaccine Market: Sepsis (2017-2022) & (K Doses) Figure 20. Global Pneumonia Vaccine Sales Market Share by Application (2017-2022) Figure 21. Global Pneumonia Vaccine Revenue Market Share by Application in 2021 Figure 22. Pneumonia Vaccine Revenue Market by Company in 2021 ($ Million) Figure 23. Global Pneumonia Vaccine Revenue Market Share by Company in 2021 Figure 24. Global Pneumonia Vaccine Sales Market Share by Geographic Region (2017-2022) Figure 25. Global Pneumonia Vaccine Revenue Market Share by Geographic Region in 2021 Figure 26. Global Pneumonia Vaccine Sales Market Share by Region (2017-2022) Figure 27. Global Pneumonia Vaccine Revenue Market Share by Country/Region in 2021 Figure 28. Americas Pneumonia Vaccine Sales 2017-2022 (K Doses) Figure 29. Americas Pneumonia Vaccine Revenue 2017-2022 ($ Millions) Figure 30. APAC Pneumonia Vaccine Sales 2017-2022 (K Doses) Figure 31. APAC Pneumonia Vaccine Revenue 2017-2022 ($ Millions) Figure 32. Europe Pneumonia Vaccine Sales 2017-2022 (K Doses) Figure 33. Europe Pneumonia Vaccine Revenue 2017-2022 ($ Millions) Figure 34. Middle East & Africa Pneumonia Vaccine Sales 2017-2022 (K Doses) Figure 35. Middle East & Africa Pneumonia Vaccine Revenue 2017-2022 ($ Millions) Figure 36. Americas Pneumonia Vaccine Sales Market Share by Country in 2021 Figure 37. Americas Pneumonia Vaccine Revenue Market Share by Country in 2021 Figure 38. United States Pneumonia Vaccine Revenue Growth 2017-2022 ($ Millions) Figure 39. Canada Pneumonia Vaccine Revenue Growth 2017-2022 ($ Millions) Figure 40. Mexico Pneumonia Vaccine Revenue Growth 2017-2022 ($ Millions) Figure 41. Brazil Pneumonia Vaccine Revenue Growth 2017-2022 ($ Millions) Figure 42. APAC Pneumonia Vaccine Sales Market Share by Region in 2021 Figure 43. APAC Pneumonia Vaccine Revenue Market Share by Regions in 2021 Figure 44. China Pneumonia Vaccine Revenue Growth 2017-2022 ($ Millions) Figure 45. Japan Pneumonia Vaccine Revenue Growth 2017-2022 ($ Millions) Figure 46. South Korea Pneumonia Vaccine Revenue Growth 2017-2022 ($ Millions) Figure 47. Southeast Asia Pneumonia Vaccine Revenue Growth 2017-2022 ($ Millions) Figure 48. India Pneumonia Vaccine Revenue Growth 2017-2022 ($ Millions) Figure 49. Australia Pneumonia Vaccine Revenue Growth 2017-2022 ($ Millions) Figure 50. Europe Pneumonia Vaccine Sales Market Share by Country in 2021 Figure 51. Europe Pneumonia Vaccine Revenue Market Share by Country in 2021 Figure 52. Germany Pneumonia Vaccine Revenue Growth 2017-2022 ($ Millions) Figure 53. France Pneumonia Vaccine Revenue Growth 2017-2022 ($ Millions) Figure 54. UK Pneumonia Vaccine Revenue Growth 2017-2022 ($ Millions) Figure 55. Italy Pneumonia Vaccine Revenue Growth 2017-2022 ($ Millions) Figure 56. Russia Pneumonia Vaccine Revenue Growth 2017-2022 ($ Millions) Figure 57. Middle East & Africa Pneumonia Vaccine Sales Market Share by Country in 2021 Figure 58. Middle East & Africa Pneumonia Vaccine Revenue Market Share by Country in 2021 Figure 59. Egypt Pneumonia Vaccine Revenue Growth 2017-2022 ($ Millions) Figure 60. South Africa Pneumonia Vaccine Revenue Growth 2017-2022 ($ Millions) Figure 61. Israel Pneumonia Vaccine Revenue Growth 2017-2022 ($ Millions) Figure 62. Turkey Pneumonia Vaccine Revenue Growth 2017-2022 ($ Millions) Figure 63. GCC Country Pneumonia Vaccine Revenue Growth 2017-2022 ($ Millions) Figure 64. Manufacturing Cost Structure Analysis of Pneumonia Vaccine in 2021 Figure 65. Manufacturing Process Analysis of Pneumonia Vaccine Figure 66. Industry Chain Structure of Pneumonia Vaccine Figure 67. Channels of Distribution Figure 68. Distributors Profiles